KELLY REAGAN: Open Payments
NPI 1861695728 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 33 payments from 11 companies in 2025. Trend: 2023 $886 · 2024 $821 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $347 |
| PFIZER INC. | 4 | $72 |
| Evofem Biosciences, Inc. | 2 | $35 |
| Exeltis, USA Inc. | 2 | $34 |
| Novo Nordisk Inc | 1 | $32 |
| Dexcom, Inc. | 1 | $28 |
| SHIELD THERAPEUTICS INC | 1 | $25 |
| MILLICENT US INC | 1 | $22 |
| Astellas Pharma US Inc | 1 | $20 |
| COLOPLAST CORP | 1 | $18 |
Products named: UBRELVY, NURTEC ODT, Phexxi, SLYND, Wegovy, QULIPTA, Dexcom G6 Transmitter, ACCRUFER.
Industry payments across TX — which companies pay providers there.
